Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Novonesis (Novozymes), headquartered in DK, is a global leader in biotechnology. The company develops and produces industrial enzymes and microorganisms. These biological solutions are utilized across various industries, including food, beverage, bioenergy, and healthcare, as well as for technical applications. Novonesis (Novozymes) focuses on optimizing processes and driving sustainable innovation with its advanced bio-based products.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Novonesis (Novozymes) is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Novonesis (Novozymes) last reported quarterly earnings on 8/19/2026 (Q2 2026). Earnings per share (EPS) came in at 2.84 DKK.
Novonesis (Novozymes) has beaten analyst EPS estimates in 0 of its last 3 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.